glp 1 and alzheimer's study GLP-1 the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential GLP-1 Medicines: What the Science

These findings show that GLP-1s may hold promise as an adjunct therapy to insulin to reduce cardiovascular and kidney disease among individuals with T1D

And since the May 2025 deadline has already passed, healthcare professionals recommend acting now rather than waiting until your supply runs out

However, the peptide remains experimental and should not be used outside controlled research

There definitely is more work to be done to understand exactly what the drugs are doing and the long-term benefits or risks

Nutrition & Lifestyle Guidance Sustainable weight loss requires dietary structure and metabolic awareness

Patients who reinitiated therapy after discontinuation were censored